Literature DB >> 25545207

Detection of constant domain of human T cell antigen receptor alpha-chain via novel monoclonal antibody 7F18.

Brendan K Reed1, Kyoo-A Lee, Michael P Bell, Diana Gil, Adam G Schrum.   

Abstract

The αβ T cell antigen receptor (TCR) endows T lymphocytes with immune specificity and controls their effector functions. Each person possesses a vast repertoire of TCRs that is generated by the well-studied processes of somatic recombination and thymic selection. While many antibodies specific for TCRβ variable domains are available, antibodies specific for human TCRα are rare. We now report a novel monoclonal antibody, 7F18, which binds to human TCRα constant region, with specificity for a denatured epitope that can be visualized by SDS-PAGE followed by Western blot. Both immature and mature TCR α-chain products can be visualized, making 7F18 potentially applicable to various biochemical assays of multiprotein complex assembly and maturation. This new monoclonal antibody provides a tool that can potentially facilitate the biochemical analysis of comprehensive populations of human αβ TCR complexes that need not be limited to small subsets of the repertoire.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25545207      PMCID: PMC4278167          DOI: 10.1089/mab.2013.0086

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  31 in total

1.  Characterization of the epitope on murine T-cell receptor (TCR) alpha proteins recognized by H28-710 monoclonal antibody.

Authors:  V Karaivanova; C Suzuki; C Howe; K P Kearse
Journal:  Hybridoma       Date:  1999-12

Review 2.  Comparative genomics of the human and mouse T cell receptor loci.

Authors:  G Glusman; L Rowen; I Lee; C Boysen; J C Roach; A F Smit; K Wang; B F Koop; L Hood
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

3.  Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3 epsilon gamma heterodimer.

Authors:  Z J Sun; K S Kim; G Wagner; E L Reinherz
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

Review 4.  Developmental regulation of alpha beta T cell antigen receptor assembly in immature CD4+CD8+ thymocytes.

Authors:  K P Kearse; J P Roberts; D L Wiest; A Singer
Journal:  Bioessays       Date:  1995-12       Impact factor: 4.345

5.  Assembly of the TCR/CD3 complex: CD3 epsilon/delta and CD3 epsilon/gamma dimers associate indistinctly with both TCR alpha and TCR beta chains. Evidence for a double TCR heterodimer model.

Authors:  E San José; A G Sahuquillo; R Bragado; B Alarcón
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

Review 6.  Structure, assembly and intracellular transport of the T cell receptor for antigen.

Authors:  M Exley; C Terhorst; T Wileman
Journal:  Semin Immunol       Date:  1991-09       Impact factor: 11.130

Review 7.  The molecular basis of allorecognition.

Authors:  L A Sherman; S Chattopadhyay
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

8.  Developmental regulation of alpha beta T cell antigen receptor expression results from differential stability of nascent TCR alpha proteins within the endoplasmic reticulum of immature and mature T cells.

Authors:  K P Kearse; J L Roberts; T I Munitz; D L Wiest; T Nakayama; A Singer
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

9.  In vitro translation and assembly of a complete T cell receptor-CD3 complex.

Authors:  J B Huppa; H L Ploegh
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

10.  Early molecular events induced by T cell receptor (TCR) signaling in immature CD4+ CD8+ thymocytes: increased synthesis of TCR-alpha protein is an early response to TCR signaling that compensates for TCR-alpha instability, improves TCR assembly, and parallels other indicators of positive selection.

Authors:  K P Kearse; Y Takahama; J A Punt; S O Sharrow; A Singer
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.